Aurobindo Pharma | ARBP - Gross Profit On Sales

Stock Price
1,234.00
Daily Change
12.00 0.98%
Monthly
8.23%
Yearly
16.64%
Q1 Forecast
1,137.71

Aurobindo Pharma reported INR51.23B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Cipla INR 41.64B 6.31B Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Hindustan Unilever INR 81.13B 1.23B Dec/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
UPL INR 55.96B 1.01B Dec/2025